nevirapine "mylan" 400 mg depottabletter
mylan ab - nevirapin - depottabletter - 400 mg
rimactan 150 mg kapsler, hårde
sandoz gmbh - rifampicin - kapsler, hårde - 150 mg
rimactan 300 mg kapsler, hårde
europharma.dk aps - rifampicin - kapsler, hårde - 300 mg
rimactan 300 mg kapsler, hårde
paranova danmark a/s - rifampicin - kapsler, hårde - 300 mg
rimactan 300 mg kapsler, hårde
2care4 aps - rifampicin - kapsler, hårde - 300 mg
pifeltro
merck sharp & dohme b.v. - doravirine - hiv infektioner - antivirale midler til systemisk anvendelse - pifeltro is indicated, in combination with other antiretroviral medicinal products, for the treatment of adults, and adolescents aged 12 years and older weighing at least 35 kg infected with hiv 1 without past or present evidence of resistance to the nnrti class.
rimactan 150 mg kapsler, hårde
2care4 aps - rifampicin - kapsler, hårde - 150 mg
dovato
viiv healthcare b.v. - dolutegravir natrium, lamivudin - hiv infektioner - antivirale midler til systemisk anvendelse - dovato er indiceret til behandling af human immundefekt virus type 1 (hiv-1) infektion hos voksne og unge over 12 år, som vejer mindst 40 kg, og som er uden kendt eller formodet resistens over for integrase inhibitor klasse, eller lamivudin.
livtencity
takeda pharmaceuticals international ag ireland branch - maribavir - cytomegalovirusinfektioner - antivirale midler til systemisk anvendelse - livtencity is indicated for the treatment of cytomegalovirus (cmv) infection and/or disease that are refractory (with or without resistance) to one or more prior therapies, including ganciclovir, valganciclovir, cidofovir or foscarnet in adult patients who have undergone a haematopoietic stem cell transplant (hsct) or solid organ transplant (sot). det bør overvejes at officielle vejledning om hensigtsmæssig brug af antivirale agenter.
moclostad 300 mg filmovertrukne tabletter
stada arzneimittel ag - moclobemid - filmovertrukne tabletter - 300 mg